| A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients R Wiesner, J Rabkin, G Klintmalm, S McDiarmid, A Langnas, J Punch, ... Liver Transplantation 7 (5), 442-450, 2001 | 305 | 2001 |
| Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation V Cuervas‐Mons, I Millan, JS Gavaler, TE Starzl, DH Van Thiel Hepatology 6 (5), 922-927, 1986 | 206 | 1986 |
| Randomized Trial of Fluconazole versus Nystatin for the Prophylaxis of Candida Infection following Liver Transplantation C Lumbreras, V Cuervas-Mons, P Jara, A Del Palacio, VS Turrion, ... Journal of Infectious Diseases 174 (3), 583-588, 1996 | 192 | 1996 |
| OUTCOME OF AUTOIMMUNE HEPATITIS AFTER LIVER TRANSPLANTATION1 E Prados, V Cuervas-Mons, M de la Mata, E Fraga, A Rimola, M Prieto, ... Transplantation 66 (12), 1645-1650, 1998 | 168 | 1998 |
| Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases V Cuervas‐Mons, AJ Martinez, A Dekker, TE Starzl, DH Van Thiel Hepatology 6 (3), 495-501, 1986 | 161 | 1986 |
| Validation and refinement of survival models for liver retransplantation HR Rosen, M Prieto, T Casanovas-Taltavull, V Cuervas-Mons, ... Hepatology 38 (2), 460-469, 2003 | 158 | 2003 |
| Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis A Albillos, V Cuervas-Mons, I Millan, T Canton, J Montes, C Barrios, ... Gastroenterology 98 (1), 134-140, 1990 | 157 | 1990 |
| Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with Covid-19: results from the ELITA/ELTR multi-center European study LS Belli, C Fondevila, PA Cortesi, S Conti, V Karam, R Adam, A Coilly, ... Gastroenterology 160 (4), 1151-1163. e3, 2021 | 146 | 2021 |
| Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin E Oton, R Barcena, JM Moreno-Planas, V Cuervas-Mons, ... American Journal of Transplantation 6 (10), 2348-2355, 2006 | 146 | 2006 |
| Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: results from a multicenter Spanish study J Briceño, M Cruz-Ramírez, M Prieto, M Navasa, JO De Urbina, R Orti, ... Journal of hepatology 61 (5), 1020-1028, 2014 | 136 | 2014 |
| Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations JM Aguado, JT Silva, M Fernández-Ruiz, E Cordero, J Fortún, C Gudiol, ... Transplantation Reviews 32 (1), 36-57, 2018 | 131 | 2018 |
| Apelin effects in human splanchnic arteries. Role of nitric oxide and prostanoids A Salcedo, J Garijo, L Monge, N Fernández, AL García-Villalón, ... Regulatory peptides 144 (1-3), 50-55, 2007 | 118 | 2007 |
| Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant A Asensio, A Ramos, V Cuervas‐Mons, E Cordero, V Sánchez‐Turrión, ... Liver Transplantation 14 (6), 799-805, 2008 | 116 | 2008 |
| Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant … Y Calmus, JR Scheele, I Gonzalez-Pinto, EJ Jaurrieta, E Klar, ... Liver Transplantation 8 (2), 123-131, 2002 | 113 | 2002 |
| Chronic renal dysfunction after liver transplantation in adult patients: prevalence, risk factors, and impact on mortality JM Moreno, V Cuervas-Mons, E Rubio, F Pons, VS Turrion, I Millán Transplantation proceedings 35 (5), 1907-1908, 2003 | 105 | 2003 |
| New concepts and best practices for management of pre-and post-transplantation cancer JM Campistol, V Cuervas-Mons, N Manito, L Almenar, M Arias, F Casafont, ... Transplantation reviews 26 (4), 261-279, 2012 | 103 | 2012 |
| Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C I Fernández, R Muñoz-Gómez, JM Pascasio, C Baliellas, N Polanco, ... Journal of hepatology 66 (4), 718-723, 2017 | 100 | 2017 |
| The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients A Roman, N Manito, JM Campistol, V Cuervas-Mons, L Almenar, M Arias, ... Transplantation Reviews 28 (2), 84-91, 2014 | 100 | 2014 |
| Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients O Len, J Gavalda, J María Aguado, N Borrell, C Cervera, ... Clinical infectious diseases 46 (1), 20-27, 2008 | 96 | 2008 |
| Mycophenolate mofetil can be used as monotherapy late after liver transplantation JMM Planas, VCM Martinez, ER Gonzalez, AG Cruz, J Lopez-Monclus, ... American Journal of Transplantation 4 (10), 1650-1655, 2004 | 93 | 2004 |
Antonio Ramos-MartinezHospital Universitario Puerta de Hierro-MajadahondaVerified email at salud.madrid.org
